Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
85.35
+1.26 (1.50%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Haemonetics Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,169 | 993.2 | 870.46 | 988.48 | 967.58 | 903.92 | 886.12 | 908.83 | 910.37 | 938.51 | Upgrade
|
Revenue Growth (YoY) | 17.67% | 14.10% | -11.94% | 2.16% | 7.04% | 2.01% | -2.50% | -0.17% | -3.00% | 5.22% | Upgrade
|
Cost of Revenue | 553.56 | 487.69 | 472.63 | 503.97 | 550.04 | 492.02 | 507.62 | 502.92 | 475.96 | 470.14 | Upgrade
|
Gross Profit | 615.1 | 505.5 | 397.84 | 484.51 | 417.54 | 411.91 | 378.49 | 405.91 | 434.42 | 468.37 | Upgrade
|
Selling, General & Admin | 376.68 | 340.14 | 275.22 | 282.02 | 273.47 | 316.52 | 301.73 | 317.22 | 337.17 | 365.98 | Upgrade
|
Research & Development | 50.13 | 46.8 | 32.86 | 30.88 | 35.71 | 39.23 | 37.56 | 44.97 | 54.19 | 54.2 | Upgrade
|
Other Operating Expenses | 32.26 | 37.81 | 0.02 | 68.26 | 24.8 | 0 | 58.59 | 87.67 | 2.52 | 1.76 | Upgrade
|
Operating Expenses | 459.06 | 424.75 | 308.09 | 381.16 | 333.99 | 355.75 | 397.88 | 449.86 | 393.88 | 421.93 | Upgrade
|
Operating Income | 156.03 | 80.75 | 89.75 | 103.35 | 83.55 | 56.16 | -19.38 | -43.94 | 40.54 | 46.43 | Upgrade
|
Interest Expense / Income | 14.63 | 17.12 | 16.83 | 16.2 | 9.91 | 4.53 | 8.1 | 9.47 | 0 | 0 | Upgrade
|
Other Expense / Income | - | - | - | - | - | -8 | - | - | 9.38 | 10.03 | Upgrade
|
Pretax Income | 141.4 | 63.63 | 72.91 | 87.15 | 73.63 | 59.63 | -27.48 | -53.42 | 31.17 | 36.4 | Upgrade
|
Income Tax | 26 | 20.25 | -6.56 | 10.63 | 18.61 | 14.06 | -1.21 | 2.16 | 14.27 | 1.25 | Upgrade
|
Net Income | 115.4 | 43.38 | 79.47 | 76.53 | 55.02 | 45.57 | -26.27 | -55.58 | 16.9 | 35.15 | Upgrade
|
Net Income Growth | 166.05% | -45.42% | 3.85% | 39.09% | 20.73% | - | - | - | -51.93% | -9.41% | Upgrade
|
Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 52 | 53 | 52 | 51 | 52 | 52 | Upgrade
|
Shares Outstanding (Diluted) | 51 | 51 | 51 | 52 | 53 | 54 | 52 | 51 | 52 | 52 | Upgrade
|
Shares Change | 0.13% | 0.12% | -1.01% | -2.13% | -1.04% | 3.84% | 1.21% | -2.26% | -0.55% | 0.23% | Upgrade
|
EPS (Basic) | 2.27 | 0.85 | 1.57 | 1.51 | 1.07 | 0.86 | -0.51 | -1.09 | 0.33 | 0.68 | Upgrade
|
EPS (Diluted) | 2.24 | 0.84 | 1.55 | 1.48 | 1.04 | 0.85 | -0.51 | -1.09 | 0.32 | 0.67 | Upgrade
|
EPS Growth | 166.67% | -45.81% | 4.73% | 42.31% | 22.35% | - | - | - | -52.24% | -9.46% | Upgrade
|
Free Cash Flow | 164.48 | 77.78 | 73.58 | 126.23 | 43.13 | 148.31 | 86.43 | 20.1 | 5.41 | 66.36 | Upgrade
|
Free Cash Flow Per Share | 3.24 | 1.52 | 1.45 | 2.49 | 0.84 | 2.81 | 1.68 | 0.40 | 0.10 | 1.29 | Upgrade
|
Gross Margin | 52.63% | 50.90% | 45.70% | 49.02% | 43.15% | 45.57% | 42.71% | 44.66% | 47.72% | 49.91% | Upgrade
|
Operating Margin | 13.35% | 8.13% | 10.31% | 10.46% | 8.63% | 6.21% | -2.19% | -4.83% | 4.45% | 4.95% | Upgrade
|
Profit Margin | 9.87% | 4.37% | 9.13% | 7.74% | 5.69% | 5.04% | -2.96% | -6.12% | 1.86% | 3.75% | Upgrade
|
Free Cash Flow Margin | 14.07% | 7.83% | 8.45% | 12.77% | 4.46% | 16.41% | 9.75% | 2.21% | 0.59% | 7.07% | Upgrade
|
Effective Tax Rate | 18.39% | 31.83% | -8.99% | 12.19% | 25.28% | 23.58% | - | - | 45.78% | 3.44% | Upgrade
|
EBITDA | 249.34 | 178.5 | 174.03 | 213.64 | 192.96 | 153.4 | 70.35 | 45.97 | 117.22 | 118.14 | Upgrade
|
EBITDA Margin | 21.34% | 17.97% | 19.99% | 21.61% | 19.94% | 16.97% | 7.94% | 5.06% | 12.88% | 12.59% | Upgrade
|
Depreciation & Amortization | 93.31 | 97.75 | 84.29 | 110.29 | 109.42 | 89.25 | 89.73 | 89.91 | 86.05 | 81.74 | Upgrade
|
EBIT | 156.03 | 80.75 | 89.75 | 103.35 | 83.55 | 64.16 | -19.38 | -43.94 | 31.17 | 36.4 | Upgrade
|
EBIT Margin | 13.35% | 8.13% | 10.31% | 10.46% | 8.63% | 7.10% | -2.19% | -4.83% | 3.42% | 3.88% | Upgrade
|